Antithrombotic reversal agents. [Review]
Citation: Emergency Medicine Clinics of North America. 32(3):715-25, 2014 Aug.PMID: 25060258Institution: MedStar Washington Hospital CenterDepartment: Emergency MedicineForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Antifibrinolytic Agents/tu [Therapeutic Use] | *Fibrinolytic Agents/ae [Adverse Effects] | *Hemorrhage/dt [Drug Therapy] | *Hemostasis/ph [Physiology] | Blood Coagulation Factors/tu [Therapeutic Use] | Emergency Service, Hospital | Hemorrhage/et [Etiology] | Hemostasis/de [Drug Effects] | Humans | Vitamin K/tu [Therapeutic Use]Year: 2014Local holdings: Available online from MWHC library: 1996 - presentISSN:- 0733-8627
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 25060258 | Available | 25060258 |
Available online from MWHC library: 1996 - present
The actively bleeding anticoagulated patient presenting to the emergency department requires rapid evaluation and treatment, which is made increasingly complicated by the ever-evolving antithrombotic treatment options used in medicine. Even with excellent supportive care, the timeliness with which reversal decisions need to be made continues to demand of the emergency practitioner a familiarity with the properties and general characteristics of a variety of antithrombotic agents. Reversal options vary and may include vitamin K, FFP, PCC, rFVIIa, platelets, and desmopressin, among others. Copyright 2014 Elsevier Inc. All rights reserved.
English